Dr Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at The University of Manchester and Consultant Medical Oncologist at The Christie NHS Foundation Trust, Manchester, UK. Dr Krebs’s expertise is in early-phase clinical trials with focus on drug development for lung cancer and precision medicine.
His translational research focuses on molecular profiling and the clinical application of circulating tumour DNA to guide personalised treatment selection and to monitor treatment response and resistance. He has been Principal or Chief Investigator on >40 and co-investigator on >75 early phase clinical trials across a broad range of novel therapies and indications.
He is lead for Precision Medicine at The Christie NHS Foundation Trust within the Experimental Cancer Medicine Team, Chief Investigator of the TARGET Precision Medicine program, Chair of the Manchester Molecular Tumour Board and co-theme lead for Clinical Trials within the Cancer Research UK Manchester-University College London, Lung Cancer Centre of Excellence.
EM-51294 - Date of preparation: January 2020